The Europe Tonometer Market would witness market growth of 5.4% CAGR during the forecast period (2023-2030).
A significant aspect anticipated to contribute to market growth is the rising prevalence of glaucoma, myopia, diabetes, and hypertension. In the upcoming years, the need for tonometers is anticipated to be driven by a rapidly expanding geriatric population, rising life expectancy, and falling mortality rates. Glaucoma is more likely to affect people over the age of 60, and beyond the age of 40, the risk rises annually.
Diabetes is a major contributor to a number of serious health conditions, including kidney failure, heart attack, stroke, blindness, and amputation of lower limbs. In comparison to their peers, Medicare beneficiaries with glaucoma had higher mean total and non-outpatient costs, higher rates of inpatient hospitalizations, higher rates of home health aide visits, and worse ophthalmologic as well as non-ophthalmologic outcomes. For those more susceptible to glaucoma, routine eye exams are particularly crucial and can assist in avoiding needless vision loss. Therefore, the demand for tonometers will rise considerably with the increase in eye checkups.
Major international corporations that work to produce products related to the incidence of chronic diseases as well as the growing elderly population, have their headquarters in European nations. The market in this region is driven by this. By 2050, there will be over 26.8 million people who are 85 years of age or older, up from 12.5 million in 2019. However, the number of people who are 100 years old or older will increase from 96 600 in 2019 to almost half a million (484 000) by that same year. Therefore, the steadily aging populations of regional nations will likely lead POAG prevalence to increase in Europe, thereby driving the market’s growth.
The Germany market dominated the Europe Tonometer Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $36.7 million by 2030. The UK market is poised to grow at a CAGR of 4.5% during (2023 - 2030). Additionally, The France market would witness a CAGR of 6.2% during (2023 - 2030).
Based on Type, the market is segmented into Applanation Tonometer, Rebound Tonometer, Indentation Tonometer, and Pascal Dynamic Contour Tonometer. Based on End-Use, the market is segmented into Ophthalmic Centers, Hospitals and Others. Based on Portability, the market is segmented into Desktop and Handheld. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Keeler Ltd. (Halma plc), Topcon Corporation, Revenio Group Oyj (Icare Finland Oy), Reichert, Inc. (Ametek, Inc.), OCULUS Optikgerate GmbH, Kowa American Corporation (Kowa Company, Ltd.), Nidek Co., Ltd., Ziemer Ophthalmic Systems AG, Canon, Inc. (Canon Medical Systems Corporation), and Tomey Corporation
Scope of the Study
Market Segments covered in the Report:
By Type

  • Applanation Tonometer
  • Rebound Tonometer
  • Indentation Tonometer
  • Pascal Dynamic Contour Tonometer


By End-Use

  • Ophthalmic Centers
  • Hospitals
  • Others


By Portability

  • Desktop
  • Handheld


By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Companies Profiled

  • Keeler Ltd. (Halma plc)
  • Topcon Corporation
  • Revenio Group Oyj (Icare Finland Oy)
  • Reichert, Inc. (Ametek, Inc.)
  • OCULUS Optikgerate GmbH
  • Kowa American Corporation (Kowa Company, Ltd.)
  • Nidek Co., Ltd.
  • Ziemer Ophthalmic Systems AG
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Tomey Corporation


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free